Oral Antibiotic Treatment for Male Urethritis
For nongonococcal urethritis in males, doxycycline 100 mg orally twice daily for 7 days is the preferred first-line treatment, with azithromycin 1 g orally as a single dose as an alternative; if β-lactams cannot be used, this is not a concern since β-lactams are not recommended for urethritis treatment—instead, use fluoroquinolones (levofloxacin 500 mg daily for 7 days) or macrolides (erythromycin base 500 mg four times daily for 7 days) as alternatives. 1
Treatment Algorithm by Urethritis Type
Nongonococcal Urethritis (NGU)
The most recent 2024 European Association of Urology guidelines provide the clearest framework 1:
First-line options:
- Doxycycline 100 mg orally twice daily for 7 days (preferred)
- Azithromycin 1.0-1.5 g orally as a single dose (alternative)
Alternative regimens when first-line cannot be used:
- Levofloxacin 500 mg orally daily for 7 days 2, 1
- Erythromycin base 500 mg orally four times daily for 7 days 3, 4
- Ofloxacin 200 mg orally twice daily for 7 days 1
Gonococcal Urethritis
The critical point: Gonococcal urethritis requires cephalosporin-based treatment, not oral β-lactams specifically. The 2024 guidelines recommend 1:
Preferred regimen:
- Ceftriaxone 1 g intramuscular or intravenous single dose PLUS
- Azithromycin 1 g orally single dose
If cephalosporin allergy exists:
- Gentamicin 240 mg intramuscular single dose PLUS azithromycin 2 g orally single dose
- Gemifloxacin 320 mg orally single dose PLUS azithromycin 2 g orally single dose
- Spectinomycin 2 g intramuscular single dose 1
Important Clinical Considerations
The β-Lactam Question
Critical caveat: Oral β-lactams (like amoxicillin or cephalexin) are not effective for urethritis treatment 2. The guidelines explicitly state this. When treating gonococcal urethritis, only parenteral ceftriaxone or cefixime (an oral cephalosporin) at specific doses are recommended. Therefore, if a patient "cannot use β-lactams," this primarily affects gonococcal urethritis treatment, where you would use the alternative regimens listed above.
Resistance Patterns Matter
The 2024 guidelines strongly emphasize avoiding azithromycin monotherapy as first-line empiric treatment to prevent resistance development in Neisseria gonorrhoeae and Mycoplasma genitalium 5, 6. Quinolone resistance in gonorrhea is widespread, making ciprofloxacin/levofloxacin unreliable for gonococcal infections 2.
Persistent or Recurrent Urethritis
If symptoms persist after initial doxycycline treatment 1:
- Azithromycin 500 mg orally on day 1, then 250 mg daily for 4 days
- Consider moxifloxacin 400 mg daily for 7-14 days if macrolide-resistant M. genitalium is suspected
If symptoms persist after initial azithromycin treatment 6:
- Moxifloxacin 400 mg orally daily for 7-14 days
- Metronidazole 400 mg twice daily for 5 days (to cover Trichomonas vaginalis)
Age-Specific Considerations
While the question mentions "tailored to age group," the guidelines do not provide age-stratified treatment recommendations for adult males. The same regimens apply across adult age groups. The key differentiator is the type of urethritis (gonococcal vs. nongonococcal) rather than patient age.
Partner Management
Essential: Sexual partners must be treated simultaneously with the same regimen while maintaining confidentiality 1. Patients should abstain from sexual intercourse for 7 days after single-dose therapy or until completion of multi-day regimens 4.
Diagnostic Approach Before Treatment
The 2024 guidelines strongly recommend 1:
- Perform nucleic acid amplification testing (NAAT) on first-void urine before treatment
- Delay treatment until results are available in patients with mild symptoms
- For symptomatic patients, empiric treatment covering both gonorrhea and chlamydia is appropriate
- Obtain urethral swab culture for gonorrhea to assess antimicrobial resistance
This evidence-based approach prevents unnecessary antibiotic exposure and guides appropriate therapy based on local resistance patterns.